Chinatsu Sakata-Sakurai
Northbrook, Illinois, United States
825 followers
500+ connections
Northbrook, Illinois, United States
825 followers
500+ connections
Activity
-
When Strangers become Friends #kelloggleaders I had the most amazing experience at Northwestern University - Kellogg School of Management - Global…
When Strangers become Friends #kelloggleaders I had the most amazing experience at Northwestern University - Kellogg School of Management - Global…
Liked by Chinatsu Sakata-Sakurai
-
🌟 One Year Down, A Lifetime of Learning Ahead! 🌟 I am thrilled to have completed my first year at the Northwestern University - Kellogg School of…
🌟 One Year Down, A Lifetime of Learning Ahead! 🌟 I am thrilled to have completed my first year at the Northwestern University - Kellogg School of…
Liked by Chinatsu Sakata-Sakurai
-
If you encounter a bear in the woods, stay calm. Identify yourself by making noise so the bear knows you are a human. We recommend using your…
If you encounter a bear in the woods, stay calm. Identify yourself by making noise so the bear knows you are a human. We recommend using your…
Liked by Chinatsu Sakata-Sakurai
Experience
-
Astellas Pharma US
-
-
-
-
-
-
-
-
Education
More activity by Chinatsu
-
Global Network Week at Northwestern was incredible. The week brings together amazing, thoughtful, inspiring #KellogLeaders from some of the world's…
Global Network Week at Northwestern was incredible. The week brings together amazing, thoughtful, inspiring #KellogLeaders from some of the world's…
Liked by Chinatsu Sakata-Sakurai
-
Thank you Brad Loncar for featuring our CEO, Nello Mainolfi, on BiotechTV to discuss Kymera's exciting achievements over the past year and how we’re…
Thank you Brad Loncar for featuring our CEO, Nello Mainolfi, on BiotechTV to discuss Kymera's exciting achievements over the past year and how we’re…
Liked by Chinatsu Sakata-Sakurai
-
This year, we embraced a new approach by empowering exceptional leaders in various domains while reinforcing a flat organizational structure that…
This year, we embraced a new approach by empowering exceptional leaders in various domains while reinforcing a flat organizational structure that…
Liked by Chinatsu Sakata-Sakurai
-
I'm pleased to share that JC Poythress (Astellas), Jin Hyung Lee (internship student), Kentaro Takeda (Astellas), and Jun Liu (Astellas) have…
I'm pleased to share that JC Poythress (Astellas), Jin Hyung Lee (internship student), Kentaro Takeda (Astellas), and Jun Liu (Astellas) have…
Liked by Chinatsu Sakata-Sakurai
-
I just wrapped up an incredible week at the Northwestern University - Kellogg School of Management Executive MBA Global Network Week! It was a…
I just wrapped up an incredible week at the Northwestern University - Kellogg School of Management Executive MBA Global Network Week! It was a…
Liked by Chinatsu Sakata-Sakurai
-
Targeting the “Impossible” Asp12 of KRAS(G12D)(ON) with an Aziridine-Containing Tri-complex | https://lnkd.in/g5a9zVuY RMC-9805 is a first-in-class,…
Targeting the “Impossible” Asp12 of KRAS(G12D)(ON) with an Aziridine-Containing Tri-complex | https://lnkd.in/g5a9zVuY RMC-9805 is a first-in-class,…
Liked by Chinatsu Sakata-Sakurai
-
I had a fantastic time running a 5k at Busse Woods this morning, hosted by a running mate. The highlight was meeting Sushmita Sheladaya, the…
I had a fantastic time running a 5k at Busse Woods this morning, hosted by a running mate. The highlight was meeting Sushmita Sheladaya, the…
Liked by Chinatsu Sakata-Sakurai
-
Montara Therapeutics, a therapeutics company aiming to revolutionize the discovery and development of brain-targeting drugs, announced today the…
Montara Therapeutics, a therapeutics company aiming to revolutionize the discovery and development of brain-targeting drugs, announced today the…
Liked by Chinatsu Sakata-Sakurai
-
#News for #investors: Astellas has announced the first quarter of the FY2024 consolidated financial results, ended June 30, 2024. Click on the link…
#News for #investors: Astellas has announced the first quarter of the FY2024 consolidated financial results, ended June 30, 2024. Click on the link…
Liked by Chinatsu Sakata-Sakurai
-
As we continue seeking regulatory approvals worldwide, we are happy to announce the Committee for Medicinal Products for Human Use (CHMP) has adopted…
As we continue seeking regulatory approvals worldwide, we are happy to announce the Committee for Medicinal Products for Human Use (CHMP) has adopted…
Liked by Chinatsu Sakata-Sakurai
-
It is great to see further validation of the Frontier Platform through the advancement of the discovery pipeline that ultimately may have the…
It is great to see further validation of the Frontier Platform through the advancement of the discovery pipeline that ultimately may have the…
Liked by Chinatsu Sakata-Sakurai
-
Excited to share our story, driven by star student Zachary Reinstein, which describes the molecular and cellular landscape of Merkel cell carcinoma…
Excited to share our story, driven by star student Zachary Reinstein, which describes the molecular and cellular landscape of Merkel cell carcinoma…
Liked by Chinatsu Sakata-Sakurai
-
The 19th term Annual #ShareholdersMeeting was held, and more shareholders attended than last year. We have adopted a hybrid remote attendance-type…
The 19th term Annual #ShareholdersMeeting was held, and more shareholders attended than last year. We have adopted a hybrid remote attendance-type…
Liked by Chinatsu Sakata-Sakurai
-
🔬 Novel #Payloads in the ADC Space! 🔬 As we've seen disclosures of several novel payloads within the #ADC space, we've taken this opportunity to…
🔬 Novel #Payloads in the ADC Space! 🔬 As we've seen disclosures of several novel payloads within the #ADC space, we've taken this opportunity to…
Liked by Chinatsu Sakata-Sakurai
-
Through the strategy of induced proximity, monovalent and heterobifunctional molecules enable the drugging of an increasingly wide range of…
Through the strategy of induced proximity, monovalent and heterobifunctional molecules enable the drugging of an increasingly wide range of…
Liked by Chinatsu Sakata-Sakurai
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More